Wanbangde Pharmaceutical Holding Group Co.,Ltd. Posted 8.7 Million Yuan Net Loss in First Three Quarters of 2023

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net loss of 8.7 million yuan in the first three quarters of 2023, reversing a net profit of 138.6 million yuan for the same period in the previous year.

Meanwhile, the company posted 1 billion yuan in revenue, down 14% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 37.8%.